Literature DB >> 3917695

The E rosette-associated antigen of T cells can be identified on blasts from patients with acute myeloblastic leukemia.

J Mirro, G R Antoun, T F Zipf, S Melvin, S Stass.   

Abstract

Monoclonal antibody T-11, considered specific for the sheep erythrocyte rosette-associated antigen of T cells, reacted with leukemic blasts from four of 23 patients with morphologic and cytochemical criteria for acute myeloblastic leukemia (AML). Although 83%, 87%, 88%, and 96% of the blasts from these patients reacted with T-11, only one patient demonstrated a small percentage of heat-stable E rosettes (5%). Antibody 9.6, which also reacts with the E rosette-associated antigen, was tested on blasts from two of the T-11-positive patients and was also strongly reactive (96% and 98%). Dual staining of blasts from these two patients demonstrated a small number of cells that simultaneously expressed the E rosette-associated antigen and myeloid-associated cytochemistries (myeloperoxidase [MPO] and Sudan black B). Additionally, leukemic blasts were identified that simultaneously expressed the E rosette-associated antigen and contained Auer rods. Antibody OKT-11 immunoprecipitated a 48,100-dalton glycoprotein from these leukemic blasts that is similar in molecular weight to that previously determined for the T cell surface protein (Tp50), thus providing strong evidence that this molecule can be found in some cases of AML. Because cells simultaneously expressing both the E rosette-associated antigen and MPO were identified, it would appear likely that leukemic blasts with only the E rosette-associated antigen or only MPO arose from the same progenitor. Our findings further demonstrate that the epitopes identified by antibodies OKT-11, T-11, and 9.6 are not always associated with, or sufficient for, 37 degrees C E rosette formation and can be found on blasts from patients with AML.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917695

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

1.  Biphenotypic leukaemia.

Authors:  A N Stark; C S Scott; R D Pyrah; B E Roberts
Journal:  J Clin Pathol       Date:  1986-03       Impact factor: 3.411

2.  Malignant histiocytosis. A phenotypic and genotypic investigation.

Authors:  G Cattoretti; A Villa; P Vezzoni; R Giardini; L Lombardi; F Rilke
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

3.  Letterer-Siwe disease: immunohistochemical evidence for a proliferative disorder involving immature cells of Langerhans lineage.

Authors:  L P Ruco; D Remotti; F Monardo; S Uccini; M L Cristiani; A Modesti; C D Baroni
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

4.  TdT expression in acute myeloid leukaemia. Haemopoietic immaturity or maturational asynchrony?

Authors:  A N Stark; I D MacKarill; H J Limbert; P Evans; C S Scott
Journal:  Blut       Date:  1988-01

5.  Diagnosis of myelomonocytic and macrophage neoplasms in routinely processed tissue biopsies with monoclonal antibody KP1.

Authors:  R A Warnke; K A Pulford; G Pallesen; E Ralfkiaer; D C Brown; K C Gatter; D Y Mason
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

6.  T cell receptor and immunoglobulin gene rearrangements in acute myeloblastic leukemia.

Authors:  G Y Cheng; M D Minden; B Toyonaga; T W Mak; E A McCulloch
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.